newsfilter
← Latest News
GlobeNewswire·

First Tracks Biotherapeutics Announces Participation in September Investor Conferences

SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in